Nuzenio

Antibody Therapeutics

Antibody Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Zymeworks (NASDAQ:ZYME) Update Puts Antibody Strategy In Focus - Kalkine MediaKalkine Media · Sun, 09 Aug 2026 09:49:00 GMT VERAXA Biotech Advances Antibody Therapeutics with Innovative BiTAC Platform - citybuzz -citybuzz - · Sat, 08 Aug 2026 00:18:46 GMT How the Challenges of Glioblastoma Treatment Highlight New Opportunities for Next-Generation Antibody Therapeutics - BioPharm InternationalBioPharm International · Fri, 07 Aug 2026 19:52:06 GMT Mediar Therapeutics enters option deal with Ono Pharma - The Pharma LetterThe Pharma Letter · Fri, 07 Aug 2026 10:18:54 GMT Mediar partners with Ono Pharma on fibro-inflammatory discovery - AllSciAllSci · Thu, 06 Aug 2026 16:25:44 GMT Mediar Therapeutics Enters into a Collaboration and Option Agreement with Ono Pharma to Develop Novel Treatments for Fibro-inflammatory Diseases - PR NewswirePR Newswire · Thu, 06 Aug 2026 11:00:00 GMT Mediar Therapeutics Enters Antibody Collaboration with Ono Pharma for Fibro-Inflammatory Diseases - BioPharm InternationalBioPharm International · Thu, 06 Aug 2026 07:00:00 GMT Building better therapeutic antibodies: the science, progress and problems to solve - Drug Target ReviewDrug Target Review · Tue, 04 Aug 2026 13:38:22 GMT

Timeline

Sun, 09 Aug 2026 09:49:00 GMTZymeworks (NASDAQ:ZYME) Update Puts Antibody Strategy In Focus - Kalkine Media

Sat, 08 Aug 2026 00:18:46 GMTVERAXA Biotech Advances Antibody Therapeutics with Innovative BiTAC Platform - citybuzz -

Fri, 07 Aug 2026 19:52:06 GMTHow the Challenges of Glioblastoma Treatment Highlight New Opportunities for Next-Generation Antibody Therapeutics - BioPharm International

Fri, 07 Aug 2026 10:18:54 GMTMediar Therapeutics enters option deal with Ono Pharma - The Pharma Letter

Thu, 06 Aug 2026 16:25:44 GMTMediar partners with Ono Pharma on fibro-inflammatory discovery - AllSci

Thu, 06 Aug 2026 11:00:00 GMTMediar Therapeutics Enters into a Collaboration and Option Agreement with Ono Pharma to Develop Novel Treatments for Fibro-inflammatory Diseases - PR Newswire

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Ono Pharma7 live mentions Fibro4 live mentions Collaboration3 live mentions Drug Target Review3 live mentions Antibody Therapeutics Market3 live mentions PR Newswire UK3 live mentions NASDAQ2 live mentions ZYME2 live mentions Update Puts Antibody2 live mentions Strategy In Focus2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Antibody Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.